We are live on ! Find out more

538 hedge funds and large institutions have $6.75B invested in Chemed in 2025 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 207 increasing their positions, 187 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 207 | Existing positions reduced: 187

0.2% more ownership

Funds ownership: 94.35%94.55% (+0.2%)

3% less funds holding

Funds holding: 554538 (-16)

16% less first-time investments, than exits

New positions opened: 61 | Existing positions closed: 73

21% less capital invested

Capital invested by funds: $8.5B → $6.75B (-$1.75B)

51% less call options, than puts

Call options by funds: $2.34M | Put options by funds: $4.77M

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
538
Holders Change
-16
Holders Change %
-2.89%
% of All Funds
7.07%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
61
Increased
207
Reduced
187
Closed
73
Calls
$2.34M
Puts
$4.77M
Net Calls
-$2.43M
Net Calls Change
-$5.39M

CHE Hedge Fund Activity: Q2 2025 in Review

538 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2025, worth a combined $6.75B — down 21% from $8.5B a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of CHE and 61 opened new positions — a net loss of 12 holders — while 187 trimmed existing stakes and 207 added.

The largest buyer was AQR Capital Management, adding an estimated $70.6M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $79.2M sold.

  • 538 institutional investors held Chemed (CHE) as of Q2 2025, down from 554 in Q1 2025.
  • Funds reported $6.75B of Chemed stock for Q2 2025, down 21% quarter-over-quarter.
  • 61 funds opened new Chemed positions in Q2 2025 and 73 closed out, a net change of -12 holders.
  • The largest Chemed buyer in Q2 2025 was AQR Capital Management, an estimated $70.6M added.
  • The largest Chemed seller in Q2 2025 was Point72 Asset Management, an estimated $79.2M sold.

Based on aggregated 13F filings for Q2 2025.